136 related articles for article (PubMed ID: 8659445)
21. Evaluation of PAPNET system for rescreening of negative cervical smears.
Ashfaq R; Liang Y; Saboorian MH
Diagn Cytopathol; 1995 Jul; 13(1):31-6. PubMed ID: 7587873
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of PAPNET-assisted cervical rescreening.
Doornewaard H; Woudt JM; Strubbe P; van de Seijp H; van den Tweel JG
Cytopathology; 1997 Oct; 8(5):313-21. PubMed ID: 9313983
[TBL] [Abstract][Full Text] [Related]
23. Automated screening for quality control using PAPNET: a study of 638 negative Pap smears.
Keyhani-Rofagha S; Palma T; O'Toole RV
Diagn Cytopathol; 1996 Jun; 14(4):316-20. PubMed ID: 8725131
[TBL] [Abstract][Full Text] [Related]
24. Costs and outcomes of PAPNET secondary screening technology for cervical cytologic evaluation. A community hospital's experience.
Brotzman GL; Kretzchmar S; Ferguson D; Gottlieb M; Stowe C
Arch Fam Med; 1999; 8(1):52-5. PubMed ID: 9932072
[TBL] [Abstract][Full Text] [Related]
25. Atypical squamous cells of undetermined significance in women over 55. Comparison with the general population and implications for management.
Rader AE; Rose PG; Rodriguez M; Mansbacher S; Pitlik D; Abdul-Karim FW
Acta Cytol; 1999; 43(3):357-62. PubMed ID: 10349362
[TBL] [Abstract][Full Text] [Related]
26. Colposcopic and histologic findings in women with a cytologic diagnosis of atypical squamous cells of undetermined significance.
Yarandi F; Izadi Mood N; Mirashrafi F; Eftekhar Z
Aust N Z J Obstet Gynaecol; 2004 Dec; 44(6):514-6. PubMed ID: 15598287
[TBL] [Abstract][Full Text] [Related]
27. Is it possible to define a better ASCUS class in cervicovaginal screening? A review of 187 cases.
Guerrini L; Sama D; Visani M; Cotignoli T; Sintoni C; Maioli P; Lanzanova G; Schincaglia P
Acta Cytol; 2001; 45(4):532-6. PubMed ID: 11480714
[TBL] [Abstract][Full Text] [Related]
28. Reducing or eliminating use of the category of atypical squamous cells of undetermined significance decreases the diagnostic accuracy of the Papanicolaou smear.
Pitman MB; Cibas ES; Powers CN; Renshaw AA; Frable WJ
Cancer; 2002 Jun; 96(3):128-34. PubMed ID: 12115299
[TBL] [Abstract][Full Text] [Related]
29. [The PAPNET system in cytological rescreening of cervical smears].
Cenci M; Nagar C; Giovagnoli MR; Vecchione A
Minerva Ginecol; 1997 Apr; 49(4):139-45. PubMed ID: 9206764
[TBL] [Abstract][Full Text] [Related]
30. ASCUS: comparative follow-up results related to previous SIL diagnosis.
Alameda F; Fuste P; Conangla M; Gimferrer E; Soler I; Antorn MT; Persico S; Carreras R; Serrano S
Eur J Gynaecol Oncol; 2000; 21(1):81-3. PubMed ID: 10726627
[TBL] [Abstract][Full Text] [Related]
31. Qualifiers of atypical squamous cells of undetermined significance help in patient management.
Collins LC; Wang HH; Abu-Jawdeh GM
Mod Pathol; 1996 Jun; 9(6):677-81. PubMed ID: 8782207
[TBL] [Abstract][Full Text] [Related]
32. [Computer-assisted rescreening of cervicovaginal smears stained by the Papanicolaou method. Evaluation of the PAPNET system apropos of 225 cases].
Vuong PN; Vacher-Lavenu MC; Marsan C; Baviera E
Arch Anat Cytol Pathol; 1995; 43(3):147-53. PubMed ID: 7574913
[TBL] [Abstract][Full Text] [Related]
33. Simulation of primary cervical cancer screening by the PAPNET system in an unscreened, high-risk community.
Michelow PM; Hlongwane NF; Leiman G
Acta Cytol; 1997; 41(1):88-92. PubMed ID: 9022732
[TBL] [Abstract][Full Text] [Related]
34. Rare atypical squamous cells of undetermined significance (ASCUS): a clinically significant diagnosis?
Hoerl HD; Roth-Cline MD; Shalkham JE; Pfister J; Stewart J; Guo Z; De Las Casas LE; Caya JG; Kurtycz DF
Diagn Cytopathol; 2002 Jul; 27(1):5-9. PubMed ID: 12112807
[TBL] [Abstract][Full Text] [Related]
35. Atypical squamous cells of undetermined significance qualified: a follow-up study.
Kline MJ; Davey DD
Diagn Cytopathol; 1996 Jun; 14(4):380-4. PubMed ID: 8725142
[TBL] [Abstract][Full Text] [Related]
36. Reproducibility of telecytology diagnosis of cervical smears in a quality assurance program: the Georgian experience.
Kldiashvili E; Schrader T
Telemed J E Health; 2011 Sep; 17(7):565-8. PubMed ID: 21851161
[TBL] [Abstract][Full Text] [Related]
37. PAPNET testing for HSILs. The few cell/small cell challenge.
Solomon HM; Frist S
Acta Cytol; 1998; 42(1):253-9. PubMed ID: 9479348
[TBL] [Abstract][Full Text] [Related]
38. Should atypical squamous cells of undetermined significance (ASCUS) be subcategorized? Accuracy analysis of Papanicolaou smears using receiver operating characteristic curves and implications for the ASCUS/squamous intraepithelial lesion ratio.
Renshaw AA; Genest DR; Cibas ES
Am J Clin Pathol; 2001 Nov; 116(5):692-5. PubMed ID: 11710685
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the PAPNET system for prescreening triage of cervicovaginal smears.
Ashfaq R; Saliger F; Solares B; Thomas S; Liu G; Liang Y; Saboorian MH
Acta Cytol; 1997; 41(4):1058-64. PubMed ID: 9250299
[TBL] [Abstract][Full Text] [Related]
40. Comparison of Papnet-assisted and manual screening of cervical smears.
Losell K; Dejmek A
Diagn Cytopathol; 1999 Oct; 21(4):296-9. PubMed ID: 10495327
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
